Treatment in the WHO guidelines is indicated in the setting of significant fibrosis or cirrhosis (APRI > 0·5 or TE showing median stiffness > 7 kPa) or HBV DNA > 2000 copies/mL with ALT above sex-specific cut-offs [6]. Here, GPT is linked to fibrosis.